Cargando…
Sustained complete response of hepatocellular carcinoma with portal vein tumor thrombus following discontinuation of sorafenib: A case report
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-associated mortality worldwide. No effective treatment has been established for unresectable advanced HCC, and the prognosis is poor. Sorafenib is an oral multi-targeted tyrosine kinase inhibitor for unresectable advanced HCC th...
Autores principales: | SHIOZAWA, KAZUE, WATANABE, MANABU, IKEHARA, TAKASHI, MATSUKIYO, YASUSHI, KOGAME, MICHIO, KANAYAMA, MASAHIRO, MATSUI, TEPPEI, KIKUCHI, YOSHINORI, ISHII, KOJI, IGARASHI, YOSHINORI, SUMINO, YASUKIYO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861562/ https://www.ncbi.nlm.nih.gov/pubmed/24348819 http://dx.doi.org/10.3892/ol.2013.1664 |
Ejemplares similares
-
Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Shiozawa, Kazue, et al.
Publicado: (2014) -
Comparison of contrast‐enhanced ultrasonograpy with Gd‐EOB‐DTPA‐enhanced MRI in the diagnosis of liver metastasis from colorectal cancer
por: Shiozawa, Kazue, et al.
Publicado: (2016) -
Usefulness of contrast-enhanced ultrasonography in the diagnosis of ruptured hepatocellular carcinoma
por: Shiozawa, Kazue, et al.
Publicado: (2013) -
A Case of Contiguous Primary Hepatic Marginal Zone B-Cell Lymphoma and Hemangioma Ultimately Diagnosed Using Contrast-Enhanced Ultrasonography
por: Shiozawa, Kazue, et al.
Publicado: (2015) -
Evaluation of sorafenib for advanced hepatocellular carcinoma with low α-fetoprotein in arrival time parametric imaging using contrast-enhanced ultrasonography
por: Shiozawa, Kazue, et al.
Publicado: (2016)